Abstract
Transforming Growth Factor-beta1 (TGF-β1) is expressed in the heart by muscle and non-muscle cardiac cells.In vitro, cardiac myocytes and non-muscle cells including cardiac fibroblasts and endothelial cells respond to regulatory effects of TGF-β1. Expression of TGF-β1 in the heart is subject to regulation by hemodynamic stimuli. Increased expression of mRNA transcripts for TGF-β1 has been reported in several models of cardiac hypertrophy. The objective of this study was to determine the effect of TGF-β1 in the myocardium. TGF-β1 was injected intravenously. Expression of mRNA transcripts for functional and structural proteins was determined by Northern hybridization analysis. DNA synthesis was determined by measurement of3H-thymidine incorporation into ventricular DNA. The results showed differential regulation of mRNAs for myocyte- and non-myocyte-specific proteins in the heart of TGF-β1 treated rats. Moderate but statistically significant decrease in DNA synthesis was observed in the heart of TGF-β1 treated rats (37.5%, P<0.025). Together, these data point to a physiological role for TGF-β1 in the heart. They further suggest that similar to its diversein vitro cell-specific regulatory effects, TGF-β1 may have multicellular targets in the heart. Effect of TGF-β1 alone or combined with those of other cytokines/hormones that come into play, as the result of its administration, may be responsible for altered gene expression and DNA synthesis in the myocardium. We propose that in experimental models of myocardial hypertrophy which are associated with increased expression of TGF-β1 in the heart, the contribution of regulatory effects of this growth factor to the manifestations of ventricular hypertrophy could be significant.
Similar content being viewed by others
References
Massague J: The transforming growth factor β family. Ann Rev Cell Biol 6: 597–641, 1990
Assoian RK, Fleurdelys BE, Stevenson HC, Miller PJ, Madtes DK, Raines EW, Ross R, Sporn MB: Expression and secretion of type β transforming growth factor by activated human macrophages. Proc Natl Acad Sci USA 84: 6020–6024, 1987
Roberts AB, Sporn M: Physiological action and clinical application of transforming growth factor β. Growth Factors 8: 1–9, 1993
Goey H, Keller, JR, Back T, Longo DL, Ruscetti FW, Wiltrout RH: Inhibition of early murine hemopoietic progenitor cell proliferation afterin vivo locoregional administration of transforming growth β1. J Immunol 143: 877–880, 1989
Eghbali, M: Cellular origin and distribution of transforming growth factor β1 in the normal rat myocardium. Bell Tiss Res 256: 553–558, 1989
Thompson NL, Bazoberry F, Speir H, Casscells W, Ferrans VJ, Flanders KD, Kondaiah P, Geiser AG, Sporn MB: Transforming growth factor-beta in acute myocardial infraction in rats. Growth Factors 1: 91–99, 1988
Heine UI, Brumester JK, Flanders KC, Danielpour D, Munoz EF, Roberts AB, Sporn MB: Localization of transforming growth factor-betal in mitochondria of murine heart and liver. Cell Regul 2: 467–477, 1991
Qian SQ, Kondaiah P, Casscells W, Roberts AB, Sport MB: A second messenger RNA species of transforming growth factor β1 in infarcted rat heart. Cell Reg 2: 241–249, 1991
Lefer AM, Tsao P, Aoki N, Pallandino MA: Mediation of cardioprotection by transforming growth factor β. Science 249: 61–64, 1990
Bhambi B Eghbali M: Effect of norepinephrine on myocardial collagen gene expression and response of cardiac fibroblasts following norepineophrine treatment. Am J Pathol 139: 1131–1142, 1991
Yao J, Eghbali M: Decreased collagen gene expression and absence of fibrosis in thyroid hormone-induced myocardial hypertrophy: Response of cardiac fibroblasts to thyroid hormonein vitro. Circ Res 72: 831–839, 1992
Villareal FJ, Dillmann WH: Cardiac hypertrophy-induced changes in messenger RNA levels for TGF-beta1, fibronectin, and collagen. Am J Physiol 262: H1861-H1866, 1992
Chomczynski P, Sacchi N: Single-step methoid of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156–159, 1987
Eghbali M, Czaja MJ, Zeydel M, Weiner FR, Zern MA, Seifter S, Blumenfeld OO: Collagen mRNAs in isolated adult heart cells. J Mol Cell Cardiol 20: 267–276, 1988
Mahdavi V, Chambers AP, Nadal-Ginard B: Cardiac alpha- and beta-myosin heavy chain genes are organized in tandem. Proc Natl Acad Sci USA 81: 2626–2630, 1984
Genovese C, Rowe D, Kream B: Construction of DNA sequences complementary to rat α1 and α1 collagen mRNA and their use in studying the regulation of type I collagen synthesis by 1,25-dihydroxy-vitamin D. Biochemistry 23: 6210–6216, 1984
Cleveland DW, Lopata MA, MacDonald RJ, Cown NJ, Rutter WJ, Kirschner MW: Number and evolutionary conservation of α- and β-tubulin and cytoplasmic β- and α-actin genes using specific clones cDNA probes. Cell 20: 95–105, 1980
Beyer EC, Paul DL, Goodenought DA: Connexin 43: A protein from rat heart homologous to a gap junction protein from lier. J Cell Biol 105: 2621–2629, 1987
Derynk R, Rhee L: Sequence of the porcine transforming growth factor-beta. Nucleic Acid Res 15: 3187, 1987
Nigro JM, Schweinfest CW, Rajkovic A, Pavlovic J, Jamal S, Dottin RB Hart JT, Kamarch ME, Rae PMM, Carty MD, Martin-DeLeon P: cDNA cloning and mapping of the human creatine kinase M gene to 19q13. Am J Hum Genet 40: 115–125, 1987
Perreau J, Lilienbaum A, Vasseur M, Paulin D: Nucleotide sequence of the human vimentin gene and regulation of its transcription in tissues and cultured cells. Gene 62: 7–16, 1988
Feinber AP, Vogelstein B: A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132: 6–13, 1983
Correra-Rotter R, Mariash CN, Rosenberg ME: Loading and transfer control for Northern hybridization. Biotechniques 12: 154–158, 1992
Russell WE, Coffey RJ, Ouellette AJ, Moses HL: Type β transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc Natl Acad Sci USA 85: 5126–5130, 1988
Eghbali M, Tomek R, Woods C Bhambi B: Cardiac fibroblasts are predisposed to convert into myocyte phenotype: Specific effect of transforming growth factor-β. Proc Natl Acad Sci 88: 795–799, 1991
Moses HL, Yang EY, Pietenpol A: TGF-β stimulation and inhibition of cell proliferation: New mechanistic insights Cell 63: 245–247, 1990
Rossi P, Karsenty G, Roberts AB, Roche NS, Sporn MB, de Crombrugghe B: A nuclear factor I binding site mediates the transcriptional activation of type I collagen promoter by transforming growth α1. Cell 52: 405–414, 1988
Eghbali M, Tomek R, Sukhatme VP, Woods C, Bhambi B: Differential effects of transforming growth factor-α1 and phorbol myristate acetate on cardiac fibroblasts. Regulation of fibrillar collagen mRNAs and expression of early transcription factors. Cir Res 69: 483–490, 1991
Spron BM, Roberts AB, Shull JH, Smith JM, Ward JM: Polypeptide transforming growth factors isolated from bovine sources and used for wound healingin vivo. Science 219: 1329–1331, 1983
Brand T, MacLellan WR, Schneider MD: a dominant-negative receptor for type-beta transforming growth factors created by deletion of the kinase domain. J Biol Chem 268: 11500–11503, 1993
Roberts AB, Roche NS, Winokur TS, Burmester JK, Sporn MB: Role of transforming growth factor b in maintenance of function of cultured neonatal cardiac myocytes: autocrine action and reversal of damaging effects of interleukin-I. J Clin Invest 90: 2056–2062, 1992
Roberts AB, Vodovotz Y, Roche NS, Sporn MB, Nathan CF: Role of nitric oxide in antagonistic effects of transforming growth factor-β and interleukin-1β on the beating rate of cultured cardiac myocytes. Mol Endo 6: 1921–1930, 1992
Olson EN, Caldwell KL, Gordon JI, Glaser L: Regulation of creatine phosphokinase expression during differentiation of BC3H1 cells. J Biol Chem 258: 2644–2652, 1983
Otsu N, Yamaguchi I, Komatsu E, Miyazawa K: Changes in creatine kinase M localization in acute ischemic myocardial cells; Immunoelectron microscopic studies. Circ Res 73: 935–942, 1993
Rumyantsev PP: In: B.M. Carlson (ed). Growth and Hyperplasia of cardiac muscle cells. Harvard, New York, 1991, pp 3–68
Agrotis A, Saltis J Bobik A: Transforming growth factor-α1 gene activation and growth of smooth muscle from hypertensive rats. Hypertension 23: 593–599, 1994
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sigel, A., Douglas, J.A. & Eghbali-Webb, M. Regulation of mRNA transcripts and DNA synthesis in the rat heart following intravenous injection of transforming growth factor beta1 . Mol Cell Biochem 141, 145–151 (1994). https://doi.org/10.1007/BF00926178
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00926178